Amyotrophic Lateral Sclerosis Treatment Market Expected To Expand At A CAGR of 5.8% From 2019 To 2026
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXHjGIkI_NJ3sy0BsbRdqToW8Ty0IOtQLVACSnaBe-J_KpbAetbDIqgko5kfUW4QPLZATaqd4Q-hR_GodXzHN8SoptlOTXsBOuSaE5Dd0qv7iZigiR9vAUHbGg60Ix-T_f3P8f9sixOdwV/s320/Amyotrophic+Lateral+Sclerosis+Treatment+Market.jpg)
San Francisco, 24 Nov 2020: The Report Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Stem Cell Transplant), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), And Segment Forecasts, 2019 - 2026 The global amyotrophic lateral sclerosis treatment market size is expected to reach USD 885.5 million by 2026, according to a new report by Grand View Research. Some of the key factors driving the market include growing awareness about ALS, increasing incidence rate, and rising geriatric population. However, the cost associated with ALS treatment is high, which may hinder the market growth during the forecast period. Currently, no cure is available for ALS and treatments such as medications and stem cell therapies can only help to slow down the disease progression, manage the symptoms, and prevent unnecessary complications. Furthermore, inclination towards a sedentary lifestyle among the geriatric population i